Literature DB >> 3749010

Ten-year evaluation of hypertension, overweight, cholesterol, and smoking control: the CHAD program in Jerusalem. Community Syndrome of Hypertension, Atherosclerosis and Diabetes.

J Gofin, R Gofin, J H Abramson, R Ban.   

Abstract

Control of hypertension, overweight, hypercholesterolemia, and smoking is a major objective of the CHAD program, a multifactorial cardiovascular risk factor program built into a family practice, which has operated in a neighborhood of western Jerusalem since 1971. By 1975-1976, there was a significantly larger decrease in risk factors in this population than in a neighboring population receiving ordinary medical care. Follow-up based on clinical records of a cohort of 441 people exposed to the program until 1981 revealed that the mean blood pressures decreased and the prevalence of hypertension continued to decrease between 1976 and 1981, from 12.5 to 9.1%. Prevalence of cigarette smoking among people ages 30 years or more also decreased in this period, mainly due to a decrease in heavy smoking, at a time when national surveys provided no evidence of a smoking decrease in this age group. Effects on overweight and cholesterol were not demonstrated during this period. This 10-year evaluation demonstrates the effects of intervention by primary care practitioners in the framework of a community-oriented program.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749010     DOI: 10.1016/0091-7435(86)90049-6

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  2 in total

1.  The Italian health surveillance (SiVeAS) prioritization approach to reduce chronic disease risk factors.

Authors:  Eduardo J Simoes; Sergio Mariotti; Alessandra Rossi; Alicia Heim; Felipe Lobello; Ali H Mokdad; Emanuele Scafato
Journal:  Int J Public Health       Date:  2012-02-14       Impact factor: 3.380

2.  The Jerusalem experience: three decades of service, research, and training in community-oriented primary care.

Authors:  Leon Epstein; Jaime Gofin; Rosa Gofin; Yehuda Neumark
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.